drugset

drugset / Trial / NCT00230490

Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201

NCT00230490 ↗

Phase 2 Terminated 150 enrolled Bausch Health Americas, Inc.

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Compare the long-term safety of pradefovir to adefovir dipivoxyl

Timeline

Start: 2005-06
Primary completion: —
Completion: 2007-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Adefovir	Unknown	—	—
Subject	pradefovir	Small molecule	—	—

Indications